Entero Healthcare Solutions shares fell 3% after Jefferies downgraded the stock to “hold” due to lower than expected Q4 results and FY26 forecasts, despite strong year-over-year revenue and profit growth. Concerns center on acquisition pace and organic growth.

• Jefferies cut price target to ₹1,320.
• Q4 revenue/profit missed estimates by 6%.
• Stock is down ~9% year, to, date.